We are live on ! Find out more
BNR

Burning Rock Biotech

52 hedge funds and large institutions have $52.5M invested in Burning Rock Biotech in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

4% more funds holding

Funds holding: 5052 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.17% less ownership

Funds ownership: 2.82%2.65% (-0.17%)

22% less capital invested

Capital invested by funds: $67.1M → $52.5M (-$14.7M)

37% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 19

Holders
52
Holders Change
+2
Holders Change %
+4%
% of All Funds
0.9%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
12
Reduced
19
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
51
Two Sigma Investments
New York
-$873K -29,988 Closed
Norges Bank
52
Norges Bank
Norway
-$815K -27,996 Closed
BBA
53
Baker Bros. Advisors
New York
-$609K -20,913 Closed
California Public Employees Retirement System
54
California Public Employees Retirement System
California
-$273K -9,376 Closed
Two Sigma Advisers
55
Two Sigma Advisers
New York
-$157K -5,400 Closed
UBS Group
56
UBS Group
Switzerland
-$93K -3,172 Closed
QT
57
Quantbot Technologies
New York
-$61K -2,104 Closed
EGM
58
Engineers Gate Manager
New York
-$34K -1,163 Closed
Carson Wealth (CWM LLC)
59
Carson Wealth (CWM LLC)
Nebraska
+$32 +1 New
SOW
60
State of Wyoming
Wyoming
+$194 +6 New

BNR Hedge Fund Activity: Q3 2022 in Review

52 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q3 2022, worth a combined $52.5M — down 22% from $67.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BNR positions and 9 closed out — a net gain of 2 holders — while 12 added to existing stakes and 19 trimmed.

The largest buyer was Kynam Capital Management, adding an estimated $7.76M. The largest seller was Vanguard Group, cutting an estimated $4.8M.

  • 52 institutional investors held Burning Rock Biotech (BNR) as of Q3 2022, up from 50 in Q2 2022.
  • Funds reported $52.5M of Burning Rock Biotech stock for Q3 2022, down 22% quarter-over-quarter.
  • 11 funds opened new Burning Rock Biotech positions in Q3 2022 and 9 closed out, a net change of +2 holders.
  • The largest Burning Rock Biotech buyer in Q3 2022 was Kynam Capital Management, an estimated $7.76M added.
  • The largest Burning Rock Biotech seller in Q3 2022 was Vanguard Group, an estimated $4.8M sold.

Based on aggregated 13F filings for Q3 2022.